首页> 外文期刊>Bangladesh Journal of Medicine >Persistent thrombocytopenia in Dengue Fever is rare but not uncommon - can be treated with steroid successfully
【24h】

Persistent thrombocytopenia in Dengue Fever is rare but not uncommon - can be treated with steroid successfully

机译:登革热的持续性血小板减少症是罕见的,但并不少见 - 可以用类固醇成功治疗

获取原文
           

摘要

Fever, skin rash, thrombocytopenia and bleeding are common manifestation of dengue fever (DF). Thrombocytopenia usually gets better and platelet count normalizes by day 10 of fever. Chronic thrombocytopenia is not a feature of dengue fever. Proposed mechanisms behind thrombocytopenia are many. Direct platelet destruction by dengue virus, immune-mediated platelet destruction and evenmegakaryocytic immune injury are proposed as underlying mechanisms. We are reporting a case of a 43 year old female who presented in dengue season in 2019 with fever and bleeding and wasdiagnosed as a case of dengue haemorrhagic fever. She had persistent thrombocytopenia which neededto be treated on the lines of immune thrombocytopenia and responded to steroids. Other causes of thrombocytopenia were ruled out.
机译:发烧,皮疹,血小板减少症和出血是登革热(DF)的常见表现。血小板减少症通常变得更好,血小板计数在发烧第10天正常化。慢性血小板减少症不是登革热的特征。血小板减少症背后的提出机制很多。先登病毒的直接血小板破坏,免疫介导的血小板破坏和偶数细胞免疫损伤被提出为潜在的机制。我们报告了一个43岁的女性,2019年在2019年在登革热赛中发烧和出血,并作为登革热出血热的案例。她患有持续的血小板减少症,需要在免疫血小板减少症的线上治疗并对类固醇进行反应。排除了其他血小板减少症的原因。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号